Richard C. Barry

Sydney, NSW, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Outcomes in Neovascular Age-Related Macular Degeneration with Visit Gaps under Anti-VEGF Therapy in Daily Practice: Data from the Fight Retinal Blindness! Registry.

Outcomes in Neovascular Age-Related Macular Degeneration with Visit Gaps under Anti-VEGF Therapy in Daily Practice: Data from the Fight Retinal Blindness! Registry.

Journal: Ophthalmology. Retina

Published: December 12, 2025

Twelve-Month Real-World Outcomes of Faricimab for Treatment-Naive Neovascular AMD in Australia.

Twelve-Month Real-World Outcomes of Faricimab for Treatment-Naive Neovascular AMD in Australia.

Journal: Clinical & experimental ophthalmology

Published: November 04, 2025

Outcomes of eyes with persistent diabetic macular oedema: The Fight Retinal Blindness! Project.

Outcomes of eyes with persistent diabetic macular oedema: The Fight Retinal Blindness! Project.

Journal: The British journal of ophthalmology

Published: September 25, 2025

Visual noise in augmented reality improves vision in age-related macular degeneration.

Visual noise in augmented reality improves vision in age-related macular degeneration.

Journal: npj aging

Published: August 19, 2025

Outcomes After Switching to Faricimab in Neovascular Age-Related Macular Degeneration: Data From the Fight Retinal Blindness! Registry.

Outcomes After Switching to Faricimab in Neovascular Age-Related Macular Degeneration: Data From the Fight Retinal Blindness! Registry.

Journal: Clinical & experimental ophthalmology

Published: March 03, 2025

Progression of Loss of Vision From Centre-Involving Macular Atrophy in Eyes Treated for nAMD.

Progression of Loss of Vision From Centre-Involving Macular Atrophy in Eyes Treated for nAMD.

Journal: Clinical & experimental ophthalmology

Published: January 08, 2025

Outlier ophthalmologists in the treatment of neovascular age-related macular degeneration with intravitreal therapy.

Outlier ophthalmologists in the treatment of neovascular age-related macular degeneration with intravitreal therapy.

Journal: The British journal of ophthalmology

Published: June 19, 2024

Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! Registry.

Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! Registry.

Journal: Clinical & experimental ophthalmology

Published: April 12, 2024

Comparing 2-dimensional macular pigment optical density with objective and subjective perimetry and visual acuity in age-related macular degeneration.

Comparing 2-dimensional macular pigment optical density with objective and subjective perimetry and visual acuity in age-related macular degeneration.

Journal: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

Published: September 20, 2023

Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema.

Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema.

Journal: PloS one

Published: November 01, 2022

Comparing Objective Perimetry, Matrix Perimetry, and Regional Retinal Thickness in Mild Diabetic Macular Edema.

Comparing Objective Perimetry, Matrix Perimetry, and Regional Retinal Thickness in Mild Diabetic Macular Edema.

Journal: Translational vision science & technology

Published: November 29, 2021

Rapid Objective Testing of Visual Function Matched to the ETDRS Grid and Its Diagnostic Power in Age-Related Macular Degeneration.

Rapid Objective Testing of Visual Function Matched to the ETDRS Grid and Its Diagnostic Power in Age-Related Macular Degeneration.

Journal: Ophthalmology science

Published: November 16, 2021

Showing 1-12 of 14

Last Updated: 09/26/2026